Divi's Laboratories Limited (BOM:532488)
India · Delayed Price · Currency is INR 8,550.00
-37.00 (-0.43%)
At close: Aug 21, 2026
Divi's Laboratories Revenue
Divi's Laboratories had revenue of 30.80B INR in the quarter ending June 30, 2026, with 27.80% growth. This brings the company's revenue in the last twelve months to 112.30B, up 16.35% year-over-year. In the fiscal year ending March 31, 2026, Divi's Laboratories had annual revenue of 105.60B with 12.82% growth.
Revenue (ttm)
112.30B
Revenue Growth
+16.35%
P/S Ratio
20.32
Revenue / Employee
9.71M
Employees
11,565
Market Cap
2.28T
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 105.60B | 12.00B | 12.82% |
| Mar 31, 2025 | 93.60B | 15.15B | 19.31% |
| Mar 31, 2024 | 78.45B | 780.00M | 1.00% |
| Mar 31, 2023 | 77.67B | -11.93B | -13.31% |
| Mar 31, 2022 | 89.60B | 19.90B | 28.56% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| IOL Chemicals and Pharmaceuticals | 25.24B |
| Neuland Laboratories | 23.72B |
| Shilpa Medicare | 16.83B |
| Bajaj HealthCare | 6.28B |
| NGL Fine-Chem | 5.36B |
| Sai Parenteral's | 5.26B |
| Anlon Healthcare | 2.26B |
| Gujarat Themis Biosyn | 1.74B |
Divi's Laboratories News
- 21 days ago - Divi's Laboratories Transcript: Q1 26/27 - Transcripts
- 21 days ago - Divi's Laboratories Quarterly report: Q1 2027 - Filings
- 5 weeks ago - Top stocks to buy today: Stock market recommendations for July 14, 2026 - check list - The Times of India
- 2 months ago - 39 Telangana cos among top 500 most valuable private sector companies in India - The Times of India
- 2 months ago - Divi's Laboratories announces ₹30 per share dividend for FY 2025-26 - Business Upturn
- 2 months ago - Pharma sector stocks today, June 9: Panacea Biotech surges 9.11%, Divis Laboratories up 3.46%, Ajanta Pharma gains 1.86% - Business Upturn
- 2 months ago - Dividend stocks in focus: Axis Bank, Divi's Laboratories, Atul, D-Link India and others announce record dates - Business Upturn
- 2 months ago - Top stocks for trade today, June 8: ONGC, Divi's Laboratories, Zee Entertainment, Amber Enterprises, TVS Motor, Hindustan Zinc and more - Business Upturn